ArticleScientific reports2024

Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients.

Zahirah Zaharuddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.